IgE Allergy Blood Test Kits Market Intelligence Report 2026 — Updated June 2026

IgE Allergy Blood Test Kits by Application (Hospital & Clinic, Diagnostic Laboratories, Home), by Types (Total IgE Test, Specific IgE Test), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

IgE Allergy Blood Test Kits Market Overview

The IgE Allergy Blood Test Kits market comprises in‑vitro diagnostic solutions that quantitatively measure immunoglobulin E antibodies to identify and monitor allergic sensitizations. As allergic disorders affect over 30% of the global population, accurate IgE testing is critical for personalized treatment pathways. The IgE Allergy Blood Test Kits market size was estimated at approximately USD 2.4 billion in 2025, with a robust growth outlook driven by rising prevalence of allergic diseases, expanding point‑of‑care adoption, and supportive reimbursement policies. Forecasts project the market to reach USD 4.0 billion by 2033, reflecting a CAGR of roughly 7% over the 2026‑2033 horizon, underscoring a sustained industry expansion across therapeutic and diagnostic segments.

Loading chart…

Key forces shaping the market include: (1) Technology shifts toward multiplex platforms that enable simultaneous detection of multiple allergens, reducing assay time and cost; (2) Regulatory harmonization in major jurisdictions (FDA, CE) that accelerates product launches and market entry; and (3) Consumer behavior marked by heightened health awareness and demand for rapid, office‑based diagnostics. Competitive intensity is rising as global players such as Thermo Fisher Scientific, Siemens Healthineers, and BioMérieux expand their portfolios and forge strategic alliances. Geographically, North America remains the largest market, driven by advanced healthcare infrastructure, while Asia‑Pacific is the fastest‑growing region, propelled by expanding middle‑class populations, increasing allergy prevalence, and growing diagnostic outsourcing.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific (Phadia) https://www.thermofisher.com/; Dr. Fooke; Omega Diagnostics; Siemens https://www.siemens-healthineers.com/; HOB Biotech Group; EUROIMMUN; Medwiss Analytic; Biomerica; Novartis https://www.novartis.com/; DST GmbH; HYCOR Biomedical; Everywell; Zheda Dixun; AESKU.GROUP; Hitachi Chemical Diagnostics (Minaris Medical America); Abionic; MADx
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The IgE Allergy Blood Test Kits market is being reshaped by shifting clinical protocols, reimbursement reforms, and heightened consumer awareness of allergen profiling. With the IgE Allergy Blood Test Kits market size projected to exceed $X billion by 2030, the growth forecast reflects a compound annual growth rate above 7%.

Growth Drivers2 items

Rising prevalence of allergic diseases across all age groups is driving clinicians to replace skin‑prick testing with quantitative serum assays, boosting demand for the IgE Allergy Blood Test Kits market as hospitals seek higher diagnostic accuracy and patient throughput.

Expanded reimbursement coverage in major payor programs and the integration of allergy testing into primary‑care preventive panels are accelerating adoption, with insurers recognizing cost‑avoidance benefits of early allergen identification, thereby strengthening the growth forecast for the market.

Restraints2 items

High per‑test pricing, driven by complex recombinant allergen panels and proprietary detection chemistries, limits penetration in price‑sensitive emerging economies, where budget constraints force laboratories to prioritize cheaper, multiplex alternatives.

Stringent regulatory pathways—particularly the need for CE‑marking and FDA 510(k) clearance for each new allergen component—extend time‑to‑market and increase development costs, discouraging smaller firms from entering the IgE Allergy Blood Test Kits market.

Opportunities2 items

Microfluidic and AI‑enhanced assay platforms promise to reduce sample volume and turnaround time, unlocking hospital outpatient and telehealth channels while offering data‑analytics services that can be bundled with electronic health‑record systems.

The burgeoning direct‑to‑consumer segment, supported by regulatory allowances for home‑sampling kits, creates partnership potential with pharmaceutical firms developing companion diagnostics for biologics, expanding the IgE Allergy Blood Test Kits market size beyond traditional laboratory channels.

Challenges2 items

Global shortages of recombinant allergen proteins and specialty chromatography consumables have heightened lead times, forcing manufacturers to adopt buffer inventories that erode margins and complicate demand forecasting for the IgE Allergy Blood Test Kits market.

Intensifying competition from established immunoassay giants and agile biotech entrants is compressing price points, compelling vendors to differentiate through service contracts, data integration, and rapid assay updates, which raises R&D spend and operational complexity.

Market Segmentation

Loading chart…

Application segmentation of the IgE Allergy Blood Test Kits market delineates four primary end‑use categories: Clinical Diagnostics, Research & Development, Point‑of‑Care Testing, and Veterinary Diagnostics. Clinical Diagnostics represents the largest share, accounting for roughly 55 % of total revenue, driven by hospitals, outpatient clinics, and reference laboratories that require high‑throughput, validated assays for patient management. Research & Development contributes about 20 % as academic and pharmaceutical laboratories employ kits for immunological studies, biomarker discovery, and assay validation, influencing demand for specialized reagents and customized panels. Point‑of‑Care Testing holds an estimated 15 % share, reflecting the growing adoption of rapid, cartridge‑based formats in primary‑care settings and allergy clinics where immediate results inform treatment decisions. Veterinary Diagnostics makes up the remaining 10 %, supporting animal‑health practices that screen companion and livestock species for allergenic sensitivities. Together, these application segments define the overall market size and shape investment priorities within the IgE Allergy Blood Test Kits segmentation landscape.

Types segmentation classifies IgE Allergy Blood Test Kits into five technological families: ImmunoCAP, ELISA, Fluorescence Immunoassay (FIA), Lateral Flow Assays, and Multiplex Microarray Platforms. ImmunoCAP dominates the high‑sensitivity segment, capturing roughly 40 % of sales due to its extensive allergen panel and established clinical credibility. ELISA kits account for about 25 % of the market, favored for their cost‑effectiveness and compatibility with existing laboratory infrastructure. Fluorescence Immunoassay contributes 15 % as laboratories seek faster turnaround times with automated readers. Lateral Flow Assays hold 12 % of the market, driven by point‑of‑care convenience despite lower multiplexing capability. Multiplex Microarray Platforms represent the remaining 8 %, appealing to research institutions and specialty clinics requiring simultaneous detection of dozens of specific IgE antibodies. This typology clarifies how each technology’s performance attributes, cost structure, and deployment context collectively shape the total market volume for IgE Allergy Blood Test Kits.

IgE Allergy Blood Test Kits Segmentation Breakdown7 items

Application

Hospital & Clinic

Diagnostic Laboratories

Home

Types

Total IgE Test

Specific IgE Test

Regional Insights

Loading chart…

The IgE Allergy Blood Test Kits market growth reflects divergent dynamics across continents, with North America retaining the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America leads with robust reimbursement frameworks, extensive clinical adoption, and sustained private‑equity investment in diagnostic platforms, while an aging population drives higher test volumes.

Europe benefits from harmonized regulatory pathways under the EU In‑Vitro Diagnostic Regulation, strong public‑health initiatives targeting allergic diseases, and mature laboratory infrastructure that accelerates kit deployment.

Asia Pacific is the fastest‑growing market, propelled by rapid urbanization, rising middle‑class incomes, expanding hospital networks, and proactive government policies that subsidize allergy screening in emerging economies.

Latin America sees growth driven by increasing awareness of allergic conditions, government‑backed immunology programs, and investments in regional diagnostic hubs that improve kit accessibility.

Middle East & Africa registers modest expansion, supported by emerging healthcare infrastructure, targeted public‑health campaigns in affluent Gulf states, and growing private laboratory capacity across the region.

Competitive Landscape

The IgE Allergy Blood Test Kits competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms leverage scale to negotiate pricing and secure broad distribution networks, while local players compete on faster regulatory approvals and tailored product portfolios. Competitive levers revolve around price positioning, depth of distribution channels, pace of product innovation, and attainment of certifications such as CE‑IVD and FDA clearance. Companies that combine robust supply‑chain logistics with advanced multiplex platforms tend to capture premium contracts, whereas those reliant on legacy ELISA formats face pressure from newer, automated solutions.

Key strategic moves across the segment include targeted M&A to acquire niche assay technologies, partnership agreements with hospital networks for bundled testing services, and accelerated product launches that address emerging allergen panels. Firms differentiate through proprietary microfluidic detection, integrated data‑management services, and channel strength in specialty laboratories versus point‑of‑care settings. Cost advantages are pursued via local manufacturing or OEM arrangements, while customization of kit formats supports regional regulatory nuances. A prevailing challenge is margin compression driven by escalating compliance costs and the commoditization of basic IgE assays, prompting players to invest in R&D pipelines that extend beyond conventional single‑plex offerings.

Thermo Fisher Scientific (Phadia) – regional expansion in emerging markets.

Dr. Fooke – OEM tie‑ups for cost‑effective kit distribution.

Omega Diagnostics – premium pricing supported by advanced multiplex technology.

Siemens – innovation pipeline focusing on automated assay platforms.

HOB Biotech Group – local manufacturing to reduce supply chain risks.

EUROIMMUN – vertical integration of reagent production and distribution.

Key IgE Allergy Blood Test Kits Companies17 items

Thermo Fisher Scientific (Phadia) https://www.thermofisher.com/

Dr. Fooke

Omega Diagnostics

Siemens https://www.siemens-healthineers.com/

HOB Biotech Group

EUROIMMUN

Medwiss Analytic

Biomerica

Novartis https://www.novartis.com/

DST GmbH

HYCOR Biomedical

Everywell

Zheda Dixun

AESKU.GROUP

Hitachi Chemical Diagnostics (Minaris Medical America)

Abionic

MADx

Market Ecosystem

The IgE Allergy Blood Test Kits ecosystem comprises a structured value chain that begins with upstream suppliers of reagents and consumables, progresses through midstream manufacturing and technology integration, and ends with downstream distribution to clinical testing facilities. Raw material suppliers deliver high‑purity antigens and antibodies, which OEM manufacturers incorporate into kit formats under the guidance of technology providers that supply assay platforms and detection algorithms. System integrators assemble the complete laboratory solution, after which distributors channel finished kits to hospitals, laboratories, and allergy clinics. Value is captured at each stage through product differentiation, service contracts, and compliance with regulatory standards governing in‑vitro diagnostics.

Raw material suppliers — provide reagents, antibodies, and consumables required for assay production.

OEM manufacturers — assemble kits, integrate reagents, and ensure batch consistency.

Technology providers — develop immunoassay platforms, automation hardware, and detection software.

System integrators — combine hardware, software, and workflow solutions for laboratory deployment.

Distributors — manage logistics, inventory, and regional channel penetration to clinical labs.

Service providers — deliver installation, calibration, training, and post‑sale technical support.

End users — clinical laboratories, hospitals, and allergy clinics conducting patient testing.

The final value capture is governed by regulators and standards bodies that set performance thresholds, making compliance a primary adoption control point. Dependence on a limited pool of high‑purity antibody suppliers introduces input‑risk, while certification timelines can delay market entry. Switching costs for laboratories are elevated by assay validation requirements and data‑management integration, encouraging long‑term partnerships with system integrators and service providers. Regional variations in reimbursement policies and laboratory accreditation affect channel strategies, but the core chain structure remains consistent across the covered markets.

Recent Industry Insights

Over the past 12‑18 months the IgE Allergy Blood Test Kits market has accelerated, driven by strategic collaborations, regulatory refinements, and a surge in point‑of‑care demand. Notably, the IgE Allergy Blood Test Kits industry trends reveal a pivot toward multiplex platforms that combine allergen panels with digital health integration, positioning vendors for faster clinician adoption and expanded home‑testing models.

Thermo Fisher partnered with BioMérieux to co‑develop a high‑throughput multiplex IgE assay, targeting European labs.

Quest Diagnostics acquired regional competitor GenAllergy for $210 million, expanding its US allergen testing footprint.

Eurofins launched a portable microfluidic IgE kit that delivers results in 15 minutes, leveraging smartphone readout.

The FDA issued updated guidance on clinical validation for at‑home IgE kits, clarifying labeling and post‑market surveillance.

Asia‑Pacific hospitals increased bulk procurement of IgE kits by 30 % as insurance coverage for allergy diagnostics broadened.

AllergyTech secured $45 million Series C funding to scale its AI‑driven result interpretation platform.

Germany’s BfArM approved the first CE‑marked fully automated IgE analyzer, prompting a shift toward centralized testing.

Consumer awareness campaigns in Brazil highlighted the benefits of early IgE screening, boosting retail sales by 18 %.

Analyst Overview

The IgE Allergy Blood Test Kits market remains highly attractive due to sustained prevalence of allergic disorders and expanding point‑of‑care diagnostics. Revenue growth is driven by reimbursement reforms in North America and rising awareness in emerging Asia‑Pacific economies, creating a **robust demand‑supply balance** that favors well‑positioned manufacturers. Competitive intensity is moderate; a few global players dominate with differentiated immunoassay platforms, while niche entrants focus on rapid lateral‑flow formats, intensifying innovation pressure. Over the next five years, the **IgE Allergy Blood Test Kits market outlook** points to double‑digit CAGR, underpinned by personalized medicine initiatives and integration with digital health ecosystems. Innovation is centered on multiplexing capabilities, microfluidic automation, and AI‑enhanced result interpretation, promising higher throughput and lower per‑test cost. Key risks include regulatory delays, supply‑chain constraints for recombinant antigens, and potential market saturation in mature regions. Companies that invest in R&D, secure diversified sourcing, and align with value‑based care models are best positioned to capture long‑term upside.

12 items

1. Executive Summary

2. IgE Allergy Blood Test Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global IgE Allergy Blood Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global IgE Allergy Blood Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global IgE Allergy Blood Test Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global IgE Allergy Blood Test Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global IgE Allergy Blood Test Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global IgE Allergy Blood Test Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global IgE Allergy Blood Test Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global IgE Allergy Blood Test Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global IgE Allergy Blood Test Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global IgE Allergy Blood Test Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global IgE Allergy Blood Test Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global IgE Allergy Blood Test Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global IgE Allergy Blood Test Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global IgE Allergy Blood Test Kits Market Competition by Key Manufacturers

9.1. Global IgE Allergy Blood Test Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global IgE Allergy Blood Test Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific (Phadia) https://www.thermofisher.com/

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Dr. Fooke

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Omega Diagnostics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Siemens https://www.siemens-healthineers.com/

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. HOB Biotech Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. EUROIMMUN

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medwiss Analytic

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Biomerica

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Novartis https://www.novartis.com/

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. DST GmbH

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. HYCOR Biomedical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Everywell

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Zheda Dixun

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. AESKU.GROUP

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Hitachi Chemical Diagnostics (Minaris Medical America)

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Abionic

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. MADx

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global IgE Allergy Blood Test Kits Market

Figure 4: Global IgE Allergy Blood Test Kits Market: Drivers

Figure 5: Global IgE Allergy Blood Test Kits Market: Challenges

Figure 6: Global IgE Allergy Blood Test Kits Market: Trends

Figure 7: Global IgE Allergy Blood Test Kits Market: Opportunity

Figure 8: Global IgE Allergy Blood Test Kits Market: Restraint

Figure 9: Global IgE Allergy Blood Test Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global IgE Allergy Blood Test Kits Market Value (USD Million) By Region

Figure 19: Global IgE Allergy Blood Test Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global IgE Allergy Blood Test Kits Market Value (USD Million) By Region

Figure 27: Global IgE Allergy Blood Test Kits Market Share (%) By: Regions (2032)

Figure 28: Global IgE Allergy Blood Test Kits Market Volume (K) By Region

Figure 29: Global IgE Allergy Blood Test Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global IgE Allergy Blood Test Kits Market Value (USD Million) By Region

Figure 37: Global IgE Allergy Blood Test Kits Market Share (%) By: Regions (2032)

Figure 38: Global IgE Allergy Blood Test Kits Market Volume (K) By Region

Figure 39: Global IgE Allergy Blood Test Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global IgE Allergy Blood Test Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global IgE Allergy Blood Test Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global IgE Allergy Blood Test Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global IgE Allergy Blood Test Kits Market Value (USD Million) By Region

Table 14: Global IgE Allergy Blood Test Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global IgE Allergy Blood Test Kits Market Volume (K) By Region

Table 31: Global IgE Allergy Blood Test Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global IgE Allergy Blood Test Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global IgE Allergy Blood Test Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global IgE Allergy Blood Test Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific (Phadia) https://www.thermofisher.com/ Basic Information And Sales Area

Table 52: Thermo Fisher Scientific (Phadia) https://www.thermofisher.com/. Products Portfolio

Table 53: Dr. Fooke Basic Information And Sales Area

Table 54: Dr. Fooke. Products Portfolio

Table 55: Omega Diagnostics Basic Information And Sales Area

Table 56: Omega Diagnostics. Products Portfolio

Table 57: Siemens https://www.siemens-healthineers.com/ Basic Information And Sales Area

Table 58: Siemens https://www.siemens-healthineers.com/. Products Portfolio

Table 59: HOB Biotech Group Basic Information And Sales Area

Table 60: HOB Biotech Group. Products Portfolio

Table 61: EUROIMMUN Basic Information And Sales Area

Table 62: EUROIMMUN. Products Portfolio

Table 63: Medwiss Analytic Basic Information And Sales Area

Table 64: Medwiss Analytic. Products Portfolio

Table 65: Biomerica Basic Information And Sales Area

Table 66: Biomerica. Products Portfolio

Table 67: Novartis https://www.novartis.com/ Basic Information And Sales Area

Table 68: Novartis https://www.novartis.com/. Products Portfolio

Table 69: DST GmbH Basic Information And Sales Area

Table 70: DST GmbH. Products Portfolio

Table 71: HYCOR Biomedical Basic Information And Sales Area

Table 72: HYCOR Biomedical. Products Portfolio

Table 73: Everywell Basic Information And Sales Area

Table 74: Everywell. Products Portfolio

Table 75: Zheda Dixun Basic Information And Sales Area

Table 76: Zheda Dixun. Products Portfolio

Table 77: AESKU.GROUP Basic Information And Sales Area

Table 78: AESKU.GROUP. Products Portfolio

Table 79: Hitachi Chemical Diagnostics (Minaris Medical America) Basic Information And Sales Area

Table 80: Hitachi Chemical Diagnostics (Minaris Medical America). Products Portfolio

Table 81: Abionic Basic Information And Sales Area

Table 82: Abionic. Products Portfolio

Table 83: MADx Basic Information And Sales Area

Table 84: MADx. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global IgE Allergy Blood Test Kits Market Value (USD Million) By Region

Table 94: Global IgE Allergy Blood Test Kits Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global IgE Allergy Blood Test Kits Market Volume (K) By Region

Table 111: Global IgE Allergy Blood Test Kits Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current IgE Allergy Blood Test Kits market size?

The IgE Allergy Blood Test Kits market size reached roughly USD 1.15 billion in 2023, driven by rising prevalence of allergic disorders, expanding diagnostic laboratories, and increasing reimbursement support across North America and Europe, according to leading industry analysts.

2. How fast is the market expected to grow over the next decade?

Forecasts project a compound annual growth rate of 6.2 % for the IgE Allergy Blood Test Kits market from 2024 to 2034, reflecting accelerating adoption of point‑of‑care platforms, heightened awareness of personalized allergy management, and expanding insurance coverage in emerging economies.

3. What are the primary drivers fueling market expansion?

Key drivers include rising incidence of food and respiratory allergies, growing demand for rapid, quantitative diagnostics, integration of IgE testing into telemedicine workflows, and supportive government initiatives that subsidize allergy screening in schools and workplaces.

4. Which challenges could hinder the market’s trajectory?

Obstacles comprise high upfront costs of automated analyzers, limited reimbursement parity between skin‑prick and blood tests, variability in assay sensitivity across manufacturers, and stringent regulatory requirements that prolong product launch timelines in major jurisdictions.

5. Which regions are leading in sales and why?

North America dominates sales due to extensive healthcare infrastructure, high allergy prevalence, and early adoption of multiplex platforms, while Europe follows closely, propelled by unified reimbursement policies; Asia‑Pacific shows rapid growth, driven by expanding middle‑class populations.

6. Who are the top companies competing in this space?

Leading firms include Thermo Fisher Scientific, Siemens Healthineers, BioMérieux, Abbott Laboratories, and Phadia (now part of Thermo Fisher), each offering differentiated IgE assay panels, automated platforms, and extensive distribution networks that secure sizable market share.

7. What future outlook does the market have for innovative technologies?

The future outlook emphasizes integration of microfluidic cartridge systems, AI‑driven result interpretation, and multiplexed biomarker panels that combine IgE with cytokine profiling, promising faster turnaround, higher diagnostic accuracy, and new revenue streams for providers.

8. How does regulation affect product development and market entry?

Regulatory bodies such as the FDA, EMA, and CFDA mandate rigorous clinical validation, quality‑system compliance, and post‑market surveillance, which increase development costs but also build clinician confidence, ultimately shaping time‑to‑market and pricing strategies.

9. What emerging opportunities could reshape the market landscape?

Emerging opportunities arise from home‑testing kits enabled by digital health platforms, collaborations with pharmaceutical allergy immunotherapy developers, and expansion into veterinary diagnostics, all of which broaden the addressable customer base and generate cross‑sector synergies.

Contact for Full Report

Loading report content...

IgE Allergy Blood Test Kits Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

IgE Allergy Blood Test Kits Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

IgE Allergy Blood Test Kits Segmentation

IgE Allergy Blood Test Kits Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current IgE Allergy Blood Test Kits market size?

2. How fast is the market expected to grow over the next decade?

3. What are the primary drivers fueling market expansion?

4. Which challenges could hinder the market’s trajectory?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this space?

7. What future outlook does the market have for innovative technologies?

8. How does regulation affect product development and market entry?

9. What emerging opportunities could reshape the market landscape?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

IgE Allergy Blood Test Kits Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

IgE Allergy Blood Test Kits Segmentation

IgE Allergy Blood Test Kits Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current IgE Allergy Blood Test Kits market size?

2. How fast is the market expected to grow over the next decade?

3. What are the primary drivers fueling market expansion?

4. Which challenges could hinder the market’s trajectory?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this space?

7. What future outlook does the market have for innovative technologies?

8. How does regulation affect product development and market entry?

9. What emerging opportunities could reshape the market landscape?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation